Article
HDAC6 inhibition to treat heart failure with preserved ejection fraction
2023-06-16
Abstract excerpt
Heart failure with preserved ejection fraction (HFpEF) is a prevalent health condition associated with high morbidity and mortality, but currently, there are few effective therapies. Our previous research showed that inhibiting histone deacetylase 6 (HDAC6) had a beneficial effect on a genetic cardiomyopathy model. The overlapping underlying mechanisms involving inflammation and metabolism between cardiomyopathy a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 16587087-e6b6-5a6f-8e83-dc9b8b5121e5
- DOI
- 10.21203/rs.3.rs-2997460/v1
